Transpact Enterprises Ltd Stock Price Today (NSE: TRANSPACT)
Fundamental Score
Transpact Enterprises Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Transpact Enterprises Ltd share price today is ₹125.25, down 4.97% on NSE/BSE as of 3 August 2026. Transpact Enterprises Ltd (TRANSPACT) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹6.93 (Cr). The 52-week high for TRANSPACT share price is ₹236.10 and the 52-week low is ₹119.55. At a P/E ratio of 77.00x, TRANSPACT is currently trading above its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 18.37% and a debt-to-equity ratio of 0.11.
Transpact Enterprises Ltd Share Price Chart — NSE/BSE Historical Performance
Transpact Enterprises Ltd share price chart: -30.08% return over the past month. 52-week high ₹236.10, 52-week low ₹119.55.
Transpact Enterprises Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹125.25 | ₹125.25 | ₹125.25 | ₹125.25 | 500.00 (Cr) | |
| ₹131.80 | ₹131.80 | ₹131.80 | ₹131.80 | 0.00 (Cr) | |
| ₹131.80 | ₹131.80 | ₹131.80 | ₹131.80 | 500.00 (Cr) | |
| ₹138.70 | ₹138.70 | ₹138.70 | ₹138.70 | 500.00 (Cr) | |
| ₹145.95 | ₹145.95 | ₹145.95 | ₹145.95 | 500.00 (Cr) | |
| ₹153.60 | ₹153.60 | ₹153.60 | ₹153.60 | 0.00 (Cr) | |
| ₹153.60 | ₹153.60 | ₹153.60 | ₹153.60 | 0.00 (Cr) | |
| ₹153.60 | ₹153.60 | ₹153.60 | ₹153.60 | 0.00 (Cr) | |
| ₹161.65 | ₹161.65 | ₹161.65 | ₹161.65 | 0.00 (Cr) | |
| ₹161.65 | ₹161.65 | ₹161.65 | ₹161.65 | 500.00 (Cr) |
Transpact Enterprises Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹125.25 | ₹125.25 | ₹125.25 | ₹125.25 | +0.00% | |
| ₹188.50 | ₹188.50 | ₹131.80 | ₹131.80 | -30.08% | |
| ₹200.00 | ₹207.75 | ₹183.00 | ₹188.50 | -5.75% | |
| ₹200.00 | ₹200.00 | ₹200.00 | ₹200.00 | +0.00% | |
| ₹196.40 | ₹200.00 | ₹196.40 | ₹200.00 | +1.83% | |
| ₹166.00 | ₹234.90 | ₹166.00 | ₹206.70 | +24.52% | |
| ₹135.00 | ₹174.75 | ₹130.20 | ₹174.70 | +29.41% | |
| ₹142.50 | ₹144.45 | ₹130.40 | ₹130.40 | -8.49% | |
| ₹165.00 | ₹165.00 | ₹119.55 | ₹137.90 | -16.42% | |
| ₹224.30 | ₹224.30 | ₹160.00 | ₹165.00 | -26.44% | |
| ₹236.10 | ₹236.10 | ₹236.10 | ₹236.10 | +0.00% | |
| ₹178.60 | ₹224.90 | ₹178.60 | ₹224.90 | +25.92% |
AI Research Briefing
Powered by Gemini · 2026-04-20
Micro-cap MedTech hopeful with terrible financials and a consulting past; sector tailwinds won't save this.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Transpact Enterprises primarily releases compliance certificates. Last price I see is on April 17, 2026.
CORE STORY (THE REAL GAME)
- MedTech sector growth potential
- Government support for domestic manufacturing
- Potential turnaround story
- Successful product launch
- Large order win
- Acquisition by a larger player
- Micro-cap liquidity risk
- Negative Free Cash Flow
- Tiny promoter holding with significant decrease
- stretched valuation
- Negative OPM
Promoter holding decreased significantly to 0.13%.
India's medical device sector is projected to grow significantly.
Poor, Free Cash Flow 5Y: ₹-0.88 Cr
Hoping to ride the MedTech wave, needs to execute flawlessly. Unlikely.
Primary Thesis Risk
Failure to transition to a profitable MedTech business.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Transpact Enterprises Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Transpact Enterprises Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TRANSPACT across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Return on Equity (18.37%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Consistent Growth Track Record (43.10% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (28.47% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (28.47% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Margin Pressure Concerns (-10.13%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 77.00x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-20.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-0.84 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (16.16%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Transpact Enterprises Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Transpact Enterprises Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Transpact Enterprises LtdTranspact Enter...Selected✓ TRANSPACT • 542765 | 39.6/100 | ₹125.25₹125 | ₹6.93₹6.93 | 77.00Average 77.0 Average | 18.37%Good 18.37% Good | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 28.47%Excellent 28.47% Excellent | 43.10%Excellent 43.10% Excellent | 0.00% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
Transpact Enterprises Ltd Quarterly Performance
Latest quarterly metrics for TRANSPACT — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
12.50%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-20.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
43.10%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
28.47%
Compounded annual net profit growth over 5 years
Transpact Enterprises Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TRANSPACT — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Transpact Enterprises Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Transpact Enterprises Ltd (TRANSPACT) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Transpact Enterprises Ltd
About TRANSPACT (Transpact Enterprises Ltd)
Transpact Enterprises Ltd. is a pioneering force in the medical equipment and supplies sector, dedicated to delivering innovative and reliable solutions that empower healthcare pro...fessionals and enhance patient outcomes. We specialize in the sourcing, distribution, and maintenance of a comprehensive range of cutting-edge medical devices, diagnostic tools, and essential supplies. Our portfolio spans across diverse medical disciplines, from advanced imaging systems and surgical instruments to patient monitoring devices and everyday consumables. We are committed to providing quality products that conform to strict quality control standards, ensuring optimal performance and safety in critical healthcare settings. Transpact works closely with its client base to offer tailored support and solutions. At Transpact Enterprises, we understand the ever-evolving needs of the healthcare industry. That's why we prioritize continuous improvement and innovation to stay at the forefront of technological advancements. Our team of experienced professionals is passionate about fostering strong partnerships with healthcare providers, offering expert guidance and technical assistance to optimize the utilization of our products. Beyond the provision of high-quality medical equipment, we offer comprehensive maintenance and repair services, ensuring the longevity and optimal functionality of the devices we supply. We strive to be more than just a supplier, we provide long lasting solutions and services. Our mission at Transpact is to contribute to a healthier future by equipping healthcare professionals with the tools they need to provide exceptional care. We operate with integrity, transparency, and a deep sense of responsibility, adhering to the highest ethical standards in all our business practices. Our commitment to excellence extends beyond the products we offer to the relationships we build with our clients, partners, and the communities we serve. Transpact Enterprises Ltd. envisions a world where innovative medical technologies are readily available to improve the lives of patients and empower healthcare providers to deliver the best possible care.
Company Details
Key Leadership
Latest News
TRANSPACT Share Price: Frequently Asked Questions
What is the current share price of Transpact Enterprises Ltd?
Transpact Enterprises Ltd (TRANSPACT) trades at ₹125.25 on NSE and BSE. Market cap ₹6.93 (Cr). Educational data only.
What is the P/E ratio of Transpact Enterprises Ltd?
Transpact Enterprises Ltd has a P/E of 77.00x vs industry average 36.70x.
What is the Bull Run score for Transpact Enterprises Ltd?
Transpact Enterprises Ltd has a Bull Run score of 39.6/100 based on 25+ financial parameters.
Does Transpact Enterprises Ltd pay dividends?
Transpact Enterprises Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Transpact Enterprises Ltd?
Transpact Enterprises Ltd has ROE of 18.37%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Transpact Enterprises Ltd?
Transpact Enterprises Ltd has debt-to-equity of 0.11.
Is Transpact Enterprises Ltd a good investment?
Bull Run gives Transpact Enterprises Ltd a score of 39.6/100. This is not investment advice — consult a SEBI-registered advisor.